Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-03-11
2010-06-22
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S520000, C514S568000, C514S621000, C514S640000, C558S411000, C548S252000, C562S475000, C564S123000
Reexamination Certificate
active
07741352
ABSTRACT:
This invention relates to novel compounds useful as modulators of the KCNQ channel, to pharmaceutical compositions comprising these compounds, and to methods of treatment herewith.
REFERENCES:
patent: 2852557 (1958-09-01), Schraufstatter
patent: 5610156 (1997-03-01), Albright et al.
patent: 5700796 (1997-12-01), Albright et al.
patent: 5753648 (1998-05-01), Albright et al.
patent: 2 232 462 (1974-01-01), None
patent: WO-96/03380 (1996-02-01), None
patent: WO-01/10380 (2001-02-01), None
patent: WO-02/062295 (2002-08-01), None
Sugiyama et al., Database Chemabs, Chemical Abstracts Service, Columbus, Ohio, Database Accession No. 1992:612486 & JP 04/154773; Green Cross Corp; May 27, 1992.
Database Beilstein, Beilstein Institute for Organic Chemistrym Frankfurt-Main, Germany; Database Accession No. BRN 4865050 & Naito et al., Chem. Pharm. Bull., vol. 39, No. 7, 1991, pp. 1736-1745.
Database Beilstein, Beilstein Institute for Organic Chemistry, Frankfurt-Main, Germany; Database Accession No. BRN2653068 & Kametani: Yakugaku Zasshi, vol. 72, 1952, pp. 1081-1083.
Database Beilstein, Beilstein Institute for Organic Chemistry, Frankfurt-Main, Germany, Database Accession No. BRN 8724243 & Marriot et al.: Chem Soc. perkin Trans, vol. 1, No. 24, 2000, pp. 4265-4278.
Database Beilstein, Beilstein Institute for Organic Chemistry, Frankfurt-Main, Germany, Database Accession No. BRN 2652765 & Berdaque et al., Bull. Chim. Soc. FR., vol. 130, 1993, pp. 475-480.
Database Beilstein, Beilstein Institute for Organic Chemistry, Frankfurt-Main, Germany, Database Accession No. BRN 5869057 & Binnemans et al.: J. Amer. Chem. Soc., vol. 122, No. 18, 2000, pp. 4335-4344.
Database Beilstein, Beilstein Institute for Organic Chemistry, Frankfurt-Main, Germany, Database Accession No. BRN 5869062 & Mikhaleva et al., Chem. Heterocycl. Compd, vol. 28, No. 3, 1992, pp. 316-320.
Database Beilstein, Beilstein Institute for Organic Chemistry, Frankfurt-Main, Germany, Database Accession No. BRN 3318003 & Nodzu et al.: Yakugaku Zasshi, vol. 79, 1959, p. 1378.
Database Beilstein, Beilstein Institute for Organic Chemistry, Frankfurt-Main, Germany, Database Accession No. BRN 1104542 & Yamamoto et al.: Chem. Pharm. Bull., vol. 44, No. 4, 1996, pp. 734-745.
Database Beilstein, Beilstein Institute for Organic Chemistry, Frankfurt-Main, Germany, Database Accession No. BRN 1825682 & Rose et al.: J. Americ. Chem. Soc., vol. 93, 1971, p. 4350, 4352 and 4353.
Database Beilstein, Beilstein Institute for Organic Chemistry, Frankfurt-Main, Germany, Database Accession No. BRN 208772 & Klosa: Arch. Pharm. vol. 289, 1956, pp. 196-199.
Database Beilstein, Beilstein Institute for Organic Chemistry, Frankfurt-Main, Germany, Database Accession No. BRN 2865481 & Walker et al.: J. Med. Chem., vol. 9, 1966, pp. 624-630.
Database Beilstein, Beilstein Institute for Organic Chemistry, Frankfurt-Main, Germany, Database Accession No. Reaction ID 4725290 & Astles et al.: Eur. J. Med. Chem. Chi., vol. 32, No. 5, 1997, pp. 409-424.
Database Beilstein, Beilstein Institute for Organic Chemistry, Frankfurt-Main, Germany, Database Accession No. BRN 5033009 & Tighineanu et al.: Tetrahedron, vol. 36, 1980, pp. 1385-1397.
Database Beilstein, Beilstein Institute for Organic Chemistry, Frankfurt-Main, Germany, Database Accession No. BRN 37756 & Shirley: J. Americ. Chem. Soc. vol. 74, 1952, p. 664.
Database Beilstein, Beilstein Institute for Organic Chemistry, Frankfurt-Main, Germany, Database Accession No. BRN 6983888 & Marcos et al.: J. Chem. Soc. Chem. Commun., vol. 21, 1989, pp. 1641-1643.
Database Beilstein, Beilstein Institute for Organic Chemistry, Frankfurt-Main, Germany, Database Accession No. BRN 3404241 & Purrello: Boll. Sedute Accad. Gioenia Sci. Nat. Catania, vol. 4, No. 3, 1957, pp. 446-450.
Database Beilstein, Beilstein Institute for Organic Chemistry, Frankfurt-Main, Germany, Database Accession No. BRN 2096811 & Kostanecki et al.: Chem. Ber, vol. 28, 1985, pp. 2302-2309.
Database Beilstein, Beilstein Institute for Organic Chemistry, Frankfurt-Main, Germany, Database Accession No. BRN 8482080 & Nishioka et al.: Synthesis, vol. 2, 2000, pp. 243-246.
Wang, Q. et al., Nature Genetics; vol. 12, pp. 17-13 (Jan. 1996).
Biervert, Christian et al., Science, vol. 279, pp. 403-406 (Jan. 1998).
Schroeder, B. C. et al.; Nature, vol. 396, pp. 687-690 (Dec. 1998).
Kubisch, Christian et al.; Cell, vol. 96, pp. 437-446 (Feb. 1999).
Schroeder, B.C. et al.; The Journal of Biological Chemistry, vol. 275, No. 31, pp. 24080-24095 (2000).
XP-002292398, Green Cross Corp.; JP 04154773 published May 27, 1992; Category: X.
Naito, Y. et al.; Chem. Pharm. Bull., vol. 39, No. 7, pp. 1736-1745 (1991).
Kametani, T. et al.; Synthesis of Isoquinoline Derivatives; Yakugaku Zasshi, vol. 72; pp. 1081-1083 (1952).
Marriott, Jonathan H. et al.; J. Chem. Soc.; Perkin Trans. 1, pp. 4265-4278 (2000).
Berdague, P. et al.; Bull. Soc. Chim. Fr.; vol. 130; pp. 475-480 (1993).
Binnemans, Koen et al.; J. Am. Chem. Soc.; vol. 122, pp. 4335-4344 (2000).
Brown William Dalby
Dahl Bjarne H.
Teuber Lene
Birch Stewart Kolasch & Birch, LLP.
Neurosearch A/S
Sackey Ebenezer
Wilson James O
LandOfFree
KCNQ channel modulating compounds and their pharmaceutical use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with KCNQ channel modulating compounds and their pharmaceutical use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and KCNQ channel modulating compounds and their pharmaceutical use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4191903